Reconfiguring Nature’s Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents
Open Access
- 8 May 2020
- journal article
- review article
- Published by MDPI AG in Nanomaterials
- Vol. 10 (5) , 906
Abstract
Apolipoproteins are critical structural and functional components of lipoproteins, which are large supramolecular assemblies composed predominantly of lipids and proteins, and other biomolecules such as nucleic acids. A signature feature of apolipoproteins is the preponderance of amphipathic α-helical motifs that dictate their ability to make extensive non-covalent inter- or intra-molecular helix–helix interactions in lipid-free states or helix–lipid interactions with hydrophobic biomolecules in lipid-associated states. This review focuses on the latter ability of apolipoproteins, which has been capitalized on to reconstitute synthetic nanoscale binary/ternary lipoprotein complexes composed of apolipoproteins/peptides and lipids that mimic native high-density lipoproteins (HDLs) with the goal to transport drugs. It traces the historical development of our understanding of these nanostructures and how the cholesterol accepting property of HDL has been reconfigured to develop them as drug-loading platforms. The review provides the structural perspective of these platforms with different types of apolipoproteins and an overview of their synthesis. It also examines the cargo that have been loaded into the core for therapeutic and imaging purposes. Finally, it lays out the merits and challenges associated with apolipoprotein-based nanostructures with a future perspective calling for a need to develop “zip-code”-based delivery for therapeutic and diagnostic applications.Keywords
Funding Information
- National Institutes of Health (GM105561; 5UL1GM118979; 5TL4GM118980; 5RL5GM118978; R25GM071638; R25HL096365)
This publication has 229 references indexed in Scilit:
- Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP PhosphodiesterasesCell, 2012
- Curcumin nanodisks: formulation and characterizationNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Apolipoprotein-induced conversion of phosphatidylcholine bilayer vesicles into nanodisksBiochimica et Biophysica Acta (BBA) - Biomembranes, 2011
- The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosisBiomaterials, 2011
- Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: A nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoidBiochimica et Biophysica Acta (BBA) - Biomembranes, 2011
- Structure of the Minimal Interface Between ApoE and LRPJournal of Molecular Biology, 2010
- The helix bundle: A reversible lipid binding motifComparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 2010
- Oxidized Low-Density Lipoprotein2009
- Serum Opacity Factor Unmasks Human Plasma High-Density Lipoprotein Instability via Selective Delipidation and Apolipoprotein A-I DesorptionBiochemistry, 2007
- All-trans-retinoic acid nanodisksInternational Journal of Pharmaceutics, 2007